Lipid peroxidation-DNA damage by malondialdehyde.

[1]  L. Marnett,et al.  Comparison of DNA adduct levels associated with oxidative stress in human pancreas. , 1998, Mutation research.

[2]  L. Marnett,et al.  Indirect mutagenesis by oxidative DNA damage: formation of the pyrimidopurinone adduct of deoxyguanosine by base propenal. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. L. Hazen,et al.  Human neutrophils employ myeloperoxidase to convert alpha-amino acids to a battery of reactive aldehydes: a pathway for aldehyde generation at sites of inflammation. , 1998, Biochemistry.

[4]  L. Marnett,et al.  Mutagenicity in Escherichia coli of the major DNA adduct derived from the endogenous mutagen malondialdehyde. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  L. Marnett,et al.  Repair of Propanodeoxyguanosine by Nucleotide Excision Repair in Vivo and in Vitro* , 1997, The Journal of Biological Chemistry.

[6]  D. Ferguson,et al.  Analysis of the malondialdehyde-2'-deoxyguanosine adduct pyrimidopurinone in human leukocyte DNA by gas chromatography/electron capture/negative chemical ionization/mass spectrometry. , 1997, Chemical research in toxicology.

[7]  L. Marnett,et al.  Development of monoclonal antibodies to the malondialdehyde-deoxyguanosine adduct, pyrimidopurinone. , 1997, Chemical research in toxicology.

[8]  K. Dhingra,et al.  Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  R. Stocker,et al.  Radical-initiated lipid peroxidation in low density lipoproteins: insights obtained from kinetic modeling. , 1996, Chemical research in toxicology.

[10]  L. Marnett,et al.  Characterization of an N6-oxopropenyl-2'-deoxyadenosine adduct in malondialdehyde-modified DNA using liquid chromatography/electrospray ionization tandem mass spectrometry. , 1996, Carcinogenesis.

[11]  M. Mutanen,et al.  Determination of DNA adducts of malonaldehyde in humans: effects of dietary fatty acid composition. , 1996, Carcinogenesis.

[12]  J. Morrow,et al.  The isoprostanes. Current knowledge and directions for future research. , 1996, Biochemical pharmacology.

[13]  L. Marnett,et al.  Characterization of endogenous DNA adducts by liquid chromatography/electrospray ionization tandem mass spectrometry , 1995 .

[14]  J. Liehr,et al.  Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis. , 1995, Carcinogenesis.

[15]  L. Valsta,et al.  32P-postlabelling determination of DNA adducts of malonaldehyde in humans: total white blood cells and breast tissue. , 1995, Carcinogenesis.

[16]  L. Marnett,et al.  Synthesis of an Oligodeoxyribonucleotide Containing the Alkaline Labile Malondialdehyde-Deoxyguanosine Adduct Pyrimido[1,2-a]purin-10(3H)-one , 1995 .

[17]  J. Morrow,et al.  Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. , 1994, Science.

[18]  F. Chung,et al.  Detection of exocyclic 1,N2-propanodeoxyguanosine adducts as common DNA lesions in rodents and humans. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  F. Granath,et al.  Studies on the relationship between hemoglobin and DNA adducts of malonaldehyde and their stability in vivo. , 1993, Carcinogenesis.

[20]  K. Hemminki,et al.  Determination of malonaldehyde-modified 2'-deoxyguanosine-3'-monophosphate and DNA by 32P-postlabelling. , 1992, Carcinogenesis.

[21]  L. Marnett,et al.  Studies of the reaction of malondialdehyde with cytosine nucleosides. , 1990, Chemical research in toxicology.

[22]  H. Esterbauer,et al.  Possible mutagens derived from lipids and lipid precursors. , 1990, Mutation research.

[23]  N. Porter.  Mechanisms for the autoxidation of polyunsaturated lipids , 1986 .

[24]  L. Marnett,et al.  Reaction of malondialdehyde with guanine nucleosides: formation of adducts containing oxadiazabicyclononene residues in the base-pairing region , 1986 .

[25]  C. Harris,et al.  Cytotoxicity, thiol depletion and inhibition of O6-methylguanine-DNA methyltransferase by various aldehydes in cultured human bronchial fibroblasts. , 1985, Carcinogenesis.

[26]  V. Nair,et al.  Novel adducts from the modification of nucleic acid bases by malondialdehyde , 1984 .

[27]  K. Ingold,et al.  Autoxidation of micelles and model membranes. Quantitative kinetic measurements can be made by using either water-soluble or lipid-soluble initiators with water-soluble or lipid-soluble chain-breaking antioxidants , 1984 .

[28]  H. Seto,et al.  Reaction of Malonaldehyde with Nucleic Acid. II. Formation of Fluorescent Pyrimido[1,2-a]purin-10(3H)-one Mononucleotide , 1983 .

[29]  S. Nesnow,et al.  The lack of initiating and/or promoting activity of sodium malondialdehyde on SENCAR mouse skin. , 1983, Cancer letters.

[30]  M. A. Tuttle,et al.  Comparison of the mutagenicities of malondialdehyde and the side products formed during its chemical synthesis. , 1980, Cancer research.

[31]  B. Goldstein,et al.  Mutagenicity of malonaldehyde, a decomposition product of peroxidized polyunsaturated fatty acids. , 1976, Science.

[32]  W. Pryor,et al.  Letter: A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation. , 1975, The Journal of organic chemistry.

[33]  R. Shamberger,et al.  Antioxidants and cancer. IV. Initiating activity of malonaldehyde as a carcinogen. , 1974, Journal of the National Cancer Institute.

[34]  M. Hamberg,et al.  On the mechanism of the biosynthesis of prostaglandins E-1 and F-1-alpha. , 1967, The Journal of biological chemistry.

[35]  J. Liehr,et al.  Lipid hydroperoxide-induced endogenous DNA adducts in hamsters: possible mechanism of lipid hydroperoxide-mediated carcinogenesis. , 1995, Archives of biochemistry and biophysics.

[36]  C. Tibbetts,et al.  Induction of mutations by replication of malondialdehyde-modified M13 DNA in Escherichia coli: determination of the extent of DNA modification, genetic requirements for mutagenesis, and types of mutations induced. , 1995, Carcinogenesis.

[37]  J. Aikens,et al.  Mechanisms and biological relevance of lipid peroxidation initiation. , 1993, Chemical research in toxicology.

[38]  D. Janero,et al.  Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. , 1990, Free radical biology & medicine.

[39]  L. Marnett,et al.  Investigation of the adducts formed by reaction of malondialdehyde with adenosine. , 1990, Chemical research in toxicology.

[40]  W. Pryor.  Oxy-radicals and related species: their formation, lifetimes, and reactions. , 1986, Annual review of physiology.

[41]  B. Ames,et al.  Naturally occurring carbonyl compounds are mutagens in Salmonella tester strain TA104. , 1985, Mutation research.

[42]  L. Marnett,et al.  Unequivocal demonstration that malondialdehyde is a mutagen. , 1983, Carcinogenesis.